Whistle-blower Suit Over Pfizer's Lipitor Unsealed

Law360, New York (August 30, 2007, 12:00 AM EDT) -- The U.S. government has declined to intervene in a whistle-blower case brought by a former medical director at Pfizer Inc. who accused the drug giant of promoting off-label uses for its cholesterol-lowering medicine Lipitor, prompting a federal judge to order that the complaint be unsealed.

In a ruling handed down Thursday in the U.S. District Court for the Eastern District of New York, Judge Edward R. Korman ordered that Dr. Jesse Polansky's complaint be unsealed and served against Pfizer.

All other contents of the court's file...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.